Advertisement
Screener

OptimizeRx Corporation (OPRX) Proceeds from Debt, Net of Issuance Costs

3.1 / 5 stars · 53/86 Roast Me

OptimizeRx Corporation Proceeds from Debt, Net of Issuance Costs

OptimizeRx Corporation (OPRX) reported Proceeds from Debt, Net of Issuance Costs of $24.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Financing Activities

us-gaap:ProceedsFromDebtNetOfIssuanceCosts · last filed 2026-08-13

  • 2026-06-30: Proceeds from Debt, Net of Issuance Costs 6 month $24.30M.
  • 2025-06-30: Proceeds from Debt, Net of Issuance Costs 6 month $0.00.
  • 2023-10-11: Proceeds from Debt, Net of Issuance Costs $40.00M.
Period endProceeds from Debt, Net of Issuance CostsProceeds from Debt, Net of Issuance Costs 6 month
2026-06-30$24.30M
10-Q · filed 2026-08-13
2025-06-30$0.00
10-Q · filed 2026-08-13
2023-10-11$40.00M
10-Q · filed 2026-08-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
TEN Holdings, Inc. (XHLD)United States$0.152B
Future FinTech Group Inc. (FTFT)$0.144B
Datavault AI Inc. (DVLT)United States$0.144B-1.77
RESOURCES CONNECTION, INC. (RGP)United States$0.129B-3.84
DHI GROUP, INC. (DHX)United States$0.205B132.15
COMSCORE, INC. (SCOR)United States$0.073B-6.35
Research Solutions, Inc. (RSSS)United States$0.071B27.67
Getty Images Holdings, Inc. (GETY)United States$0.068B-2.33
FiscalNote Holdings, Inc. (NOTE)United States$0.065B
Bridger Aerospace Group Holdings, Inc. (BAER)United States$0.049B-9.14